Lasse Nieminen

Tampere, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

KRAS and NRAS mutations in Nordic population-based and real-world metastatic colorectal cancer cohorts.

KRAS and NRAS mutations in Nordic population-based and real-world metastatic colorectal cancer cohorts.

Journal: BJC reports

Published: July 11, 2025

Predictors of long-term survival for patients with pancreatic neuroendocrine neoplasm in FinPanNET: nationwide biobank study with histopathological re-evaluation.

Predictors of long-term survival for patients with pancreatic neuroendocrine neoplasm in FinPanNET: nationwide biobank study with histopathological re-evaluation.

Journal: The British journal of surgery

Published: May 22, 2025

Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study).

Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study).

Journal: Cancers

Published: February 07, 2024

Immunohistochemical Glucagon-like Peptide-1 Receptor Expression in Human Insulinomas.

Immunohistochemical Glucagon-like Peptide-1 Receptor Expression in Human Insulinomas.

Journal: International journal of molecular sciences

Published: August 23, 2023

Atypical (non-V600E) BRAF mutations in metastatic colorectal cancer in population and real-world cohorts.

Atypical (non-V600E) BRAF mutations in metastatic colorectal cancer in population and real-world cohorts.

Journal: International journal of cancer

Published: March 01, 2023

Immunohistochemical somatostatin receptor expression in insulinomas.

Immunohistochemical somatostatin receptor expression in insulinomas.

Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Published: January 06, 2023

Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study.

Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study.

Journal: The British journal of surgery

Published: August 16, 2022

Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study.

Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study.

Journal: British journal of cancer

Published: February 14, 2022

An easily adaptable validated risk score predicts cancer-specific survival in stage II colon cancer.

An easily adaptable validated risk score predicts cancer-specific survival in stage II colon cancer.

Journal: Acta oncologica (Stockholm, Sweden)

Published: October 12, 2020

Showing 1-9 of 9

Last Updated: 09/26/2026